Human metabolic disorders such as cardiovascular disease, obesity and metabolic syndrome are linked to changes in fatty acid or cholesterol biosynthesis; processes controlled by the sterol regulatory element binding protein (SREBP) family of transcription factors. To examine SREBP function in vivo, and to delineate SREBP transcriptional functions, we have examined SREBP (SBP-1) gene regulatory mechanisms in C. elegans, combined with complementary studies in mammalian cell lines. SREBP activates genes important for cholesterol, fatty acid and phospholipid biosynthetic pathways, in addition to ensuring production of co-factors such as Acetyl-CoA and NADPH. We have identified a novel set of SREBP-responsive genes in C. elegans, the methyl-group producing enzymes of the 1-carbon cycle (1CC). Multiple genes in this pathway, including
sams-1(MAT1A) are responsive to SBP-1/SREBP in both C. elegans and mammalian cells.
sams-1/MAT1A encodes a s-adenosyl methionine transferase, which provides the methyl donor (SAMe) for most methylation reactions. We hypothesize these genes are important components of SREBP function because methylation is necessary for phospholipid biogenesis, particularly the synthesis of phosphatidylcholine. Interference with the 1CC in C. elegans through RNAi or in
sams-1(
ok3033) disrupts lipid homeostasis, resulting in the accumulation of fat droplets in the intestine and body cavity. Importantly, this phenotype is highly reminiscent of lipid accumulation in fatty liver disease in humans and similar to the MAT1A KO in mice (Lu et al PNAS, 2001). Furthermore, we have found that phosphatidylcholine levels are low in
sams-1(RNAi) animals suggesting that defects in phospholipid metabolism could contribute to the phenotypes of these animals. SInce
sbp-1 is necessary for fat storage, it is surprising that a SBP-1 regulated gene causes increases in lipids. We have found that several SBP-1 target genes that also important for lipid metabolism (fatty acid desaturases
fat-5,
fat-6 and
fat-7) are strongly upregulated in
sams-1(RNAi) animals. In addition,
sbp-1 and the FA desaturases are necessary for lipid accumulation in
sams-1(RNAi) animals, suggesting that changes in 1C metabolism could impact key aspects of lipid biosynthesis through SBP-1. Alterations in 1C metabolism and SREBP function are associated with similar diseases, suggesting that co-regulation with lipid homeostasis may be a common impact point in metabolic disorders.